Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Manuel Monreal
- Study ID
- NCT02832245
- Status
- Recruiting
Conditions
- Venous Thromboembolism
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.
Key Dates
- Start date
- Mar 31, 2001
- Status verified
- May 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 120,000 participants (estimated)
Primary Outcome Measure
VTE events and complications [ Time Frame: 3 years ]
Central Contacts
- Mayra Hawkins0034915357183
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale University School of Medicine | New Haven | Connecticut | 06510 | - |
| College of Medicine - Jacksonville University of Florida | Jacksonville | Florida | 32209 | Luis Ortega Paz (PRINCIPAL_INVESTIGATOR) |
| Evanston NorthShore University HealthSystem | Evanston | Illinois | 60201 | Alfonso Tafur Alfonso Tafur (PRINCIPAL_INVESTIGATOR) |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Gaurav M Parmar Gaurav M Parmar (PRINCIPAL_INVESTIGATOR) |
| Northwell Health System | Manhasset | New York | 11021 | - |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in New Haven, CT
Related Studies
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint ArthroplastyPHASE2 · Recruiting · University of Miami · Miami, Florida
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein ThrombosisRecruiting · Inari Medical · Scottsdale, Arizona